CLINICAL STUDY
Effects of nitroglycerin treatment on baroreflex sensitivity andshort-term heart rate variability in humans
Tommaso Gori, MDa,
John S. Floras, MD, DPhila and
John D. Parker, MDa,*
a Division of Cardiology, Department of Medicine, Mount Sinai Hospital, and the University Health Network Hospitals, Toronto, Canada.
Manuscript received March 30, 2002;
revised manuscript received August 9, 2002,
accepted August 26, 2002.
* Reprint requests and correspondence: Dr. John D. Parker, Division of Cardiology, Department of Medicine, Mount Sinai Hospital, Suite 1609, 600 University Avenue, Toronto, Ontario, Canada, M5G 1X5. jdp{at}inforamp.net
OBJECTIVES: We set out to determine the effect of sustained treatment with nitroglycerin (GTN) on neural modulation of heart rate in humans.
BACKGROUND: Acutely, exogenous and endogenous nitric oxide reduces sympathetic, while increasing vagal, outflow. An animal study showed loss of these effects during nitrate tolerance.
METHODS: A total of 29 healthy men (age range, 18 to 32 years) received transdermal GTN (0.6 mg/h/24 h) or no therapy for six days in a parallel controlled trial. The reflex regulation of heart rate was assessed with the spontaneous baroreflex sensitivity (BRS) method. Heart rate variability was calculated both in time (standard deviation of mean RR interval [RRSD]) and frequency domains (Fast Fourier Transformation) over 10-min intervals.
RESULTS: Systolic blood pressure was unchanged after continuous GTN, whereas mean RR interval decreased significantly (from 839 to 781 ms, p < 0.05). Nitroglycerin blunted BRS (p < 0.05). When compared with untreated subjects, RRSD was significantly lower after GTN, whereas the ratio of low to high frequencies was increased (all p < 0.05).
CONCLUSIONS: Chronic GTN reduces tonic and reflex vagal heart rate modulation, resulting in greater relative sympathetic influence. Importantly, such changes in the regulation of chronotropic oscillations might have negative prognostic implications in both heart failure and coronary artery disease. Furthermore, because chronic GTN alters the blood pressure/heart rate relationship, our data suggest caution when using these variables as pharmacodynamic markers for the development of nitrate tolerance.
|
Abbreviations and Acronyms
| | ANCOVA | | analysis of covariance | | BRS | | baroreflex sensitivity | | GTN | | nitroglycerin | | HFnu | | high-frequency components of spectral analysis (normalized units) | | HRV | | heart rate variability | | LF | | low-frequency components of spectral analysis | | LF/HF | | ratio of low- to high-frequency components | | NO | | nitric oxide | | RRSD | | standard deviation of RR intervals |
|
This article has been cited by other articles:

|
 |

|
 |
 
T. Gori and J. D. Parker
Nitrate-Induced Toxicity and Preconditioning: A Rationale for Reconsidering the Use of These Drugs
J. Am. Coll. Cardiol.,
July 22, 2008;
52(4):
251 - 254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Dragoni, T. Gori, M. Lisi, G. Di Stolfo, A. Pautz, H. Kleinert, and J. D. Parker
Pentaerythrityl Tetranitrate and Nitroglycerin, but not Isosorbide Mononitrate, Prevent Endothelial Dysfunction Induced by Ischemia and Reperfusion
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2007;
27(9):
1955 - 1959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gori and J. D. Parker
Long-term therapy with organic nitrates: The pros and cons of nitric oxide replacement therapy
J. Am. Coll. Cardiol.,
August 4, 2004;
44(3):
632 - 634.
[Full Text]
[PDF]
|
 |
|
|